Clarametyx Biosciences Stock

www.clarametyx.comHealthcare / BioTech & PharmaFounded: 2019

Clarametyx Biosciences is a developer of immune therapies in the replacement of antibiotics. With a mission to treat life-threatening infections and reduce antibiotic resistance, their platform works to protect bacteria with pathogen-agnostic biologic technology. Key focus areas of the company include clinical development of moderate to severe pneumonia and treatment for chronic diseases like cystic fibrosis. Clarametyx Biosciences was founded by Michael Triplett and Peter Kleinhenz in 2020 and is headquartered in Columbus, OH.

Register To Buy and Sell Shares

For more details on financing and valuation for Clarametyx Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Clarametyx Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Clarametyx Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Clarametyx Biosciences investors also invested in these private companies

Clarametyx Biosciences’ stock FAQs


Can you buy Clarametyx Biosciences’ stock?

Clarametyx Biosciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Clarametyx Biosciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Clarametyx Biosciences’ stock?

Yes, you can sell stock of a private company like Clarametyx Biosciences. Forge can help you sell your Clarametyx Biosciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Clarametyx Biosciences’ stock price?

Clarametyx Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Clarametyx Biosciences’ private market stock price with Forge Data.

What is Clarametyx Biosciences’ stock ticker symbol?

Clarametyx Biosciences does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Clarametyx Biosciences Raises $33M in Series A Financing

In an investment led by Ohio Innovation Fund, the clinical stage Clarametyx Biosciences raised $33 million.
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.